Multi-Lineage Progenitor Cell™ (MLPC®)

The first commercially available, human umbilical cord blood-derived, clonal, multipotent stem cell line. For research use only.

Multi-Lineage Progenitor Cell (MLPC®) clonal cell lines are karyotypically normal, multipotent progenitor cells obtained from post-partum human umbilical cord blood, which have been expanded from a single cell. The MLPC has been analyzed for gene expression and has been shown to be a very early progenitor cell capable of extensive differentiation. 

Benefits of the MLPC

• Readily available inventory
• Clonal - highly repeatable experimentation
• Umbilical cord blood source - no ethical controversy
• Genetically normal and stable - not immortalized
• Highly characterized and multipotent
• Robust expansion capabilities without differentiating or losing "stem-ness" qualities

Potential MLPC Applications

• Alternative to primary tissue culture
• Disease modeling
• In vitro toxicology models
• Compound screening
• Regenerative medicine / cellular therapy
• Humanized animal models
• Studying developmental pathways